AI Thinking

Why the NHS’s 10 year plan will put the NHS further behind

Will fixing the foundations of sick care jeopardise innovation in preventative health care?

Katie Lips, CEO and Founder of Rebel Futures/10 February 2026
Why the NHS’s 10 year plan will put the NHS further behind

There’s no denying AI’s role in the future of healthcare. Healthtech is hot right now, and is ranked as the second most VC-funded sector, “securing $4.2 billion in new investment in 2025”. Indeed, no self-respecting health company is not exploring how AI will accelerate its capabilities across diagnostics, drug discovery, digital therapeutics or patient care.

AI is changing the face of health care, yet while health tech innovators are developing AI to sell into the NHS, I fear the NHS is merely planning to play catch-up rather than harnessing true AI transformation. The NHS is too busy fixing broken processes and systems to look towards the real prize.

The government has pledged over £25.6 billion “to deliver an extra two million operations, scans and appointments a year, so waiting times are reduced for you and your family” as part of its fixing the foundations strategy.

We should all be super happy about this: waiting lists will come down, we can get much-needed healthcare sooner, and that’s a good thing, right? Well, in some cases, yes. If you have chronic pain and need steroid injections or physiotherapy, for example, getting care sooner is most definitely good. Of course, we want shorter waiting times or no waiting times. But what are they not investing in when they invest in more of the same? And it is more of the same. This strategy assumes that if you do more of it - more appointments in this case, then you get better health outcomes. I am not sure that’s true.

As a healthtech founder, I attended an event by Oxford-based health tech accelerator The Hill, aiming to signpost clinicians and innovators towards supporting the plan, I suppose. I think everyone there agreed the word ‘plan’ has been seriously stretched in this instance.

The NHS’s ambition is split into 3 “radical” shifts, as they call them:

  • hospital to community;
  • analogue to digital; and
  • sickness to prevention.

Let’s look at the shift “from analogue to digital: power in your hands”. Government says: “This plan will take the NHS from the 20th-century technological laggard it is today, to the 21st-century leader it has the potential to be. To do this, we will use the unique advantages of the NHS’s healthcare model - world-leading data, its power in procurement, its means to deliver equal access - to create the most digitally accessible health system in the world. Patients will have a ‘doctor in their pocket’ in the form of the NHS App, while staff will be liberated from a burden of bureaucracy and administration.”

A lot of handwaving, then, about digital enablement. But read the actual list of what this includes, and it’s all just so basic. There’s nothing radical about this. Radical is not even a stretch in this context. The government acknowledges this is stuff that should have been available years ago, but taking politics out of this and viewing this from a purely digital innovation perspective, this is alarming.

All of the things in the list need doing, from accessible care via the NHS app to booking a GP appointment with ease; yes, we need this stuff. But there’s nothing progressive in this list; it is all about playing digital catch-up. And as most people in the digital world know, if you’re playing catch-up, you’ve lost before you’ve begun.

I am not saying these things aren’t needed. They are. But where’s the innovation, where’s the harnessing of AI that leads to disease prevention? How can they leverage AI to prevent disease so we wouldn’t need so many hospital appointments in the first place? Where’s the AI that can free up clinicians to do their best work, and not battle systems?

A few weeks ago, I attended an event in parliament called “Unlocking the Future of UK Health and Life Sciences” run by Curia, whose members shared their achievements and vision for what’s next for AI in healthcare. Opportunities were explored, and challenges shared. The audience of mainly health professionals nodded enthusiastically.

What seemed to go down really well was the contribution by Tortus CEO Dr Dom Pimenta. Tortus is an AI scribe used not only to transcribe appointments but to interact with systems as an agent. Its competitors in a similar space are Accurx and Heidi Health. All bring different innovations to the problem that doctors need to free up their time to be doctors, not note takers.

Dr Pimenta talked about how, as a good product innovator, his team worked closely with clinicians to really understand how they work. Similarly, Accurx states on its website that not only did the founding team base themselves in the GP practices in 2018, but staff regularly spend weeks in GP surgeries to understand the problems faced by doctors. From a product perspective, this is right; you have to understand your customers’ pain points. All good product people work with their customers, but it seems odd to me that in healthcare, working with customers is seen as novel.

From an NHS strategy perspective, there’s still a lot of excitement around fixing problems that have been around for years, rather than building for the future. AI scribes are clearly needed, and clearly help, and I suppose this is classed as AI innovation. But somehow it doesn’t feel all that exciting.

The shift ‘from hospital to community’ in the 10 year plan mentions it will “free up hospitals to prioritise safe deployment of AI and harness new technology to bring the very best of cutting-edge care to all patients. All hospitals will be fully AI-enabled within the lifetime of this plan.”

“Fully AI enabled”? What does this mean exactly? What does this mean at all? I can’t take that statement seriously, I’m afraid. Maybe this means all clinicians use an AI scribe, integrated with patient records that can streamline their workloads, gather data, and analyse it at scale to spot patterns and create new models of care. Maybe indeed.

There are other mentions of AI and data, and to be honest, they sound a little more grounded in reality, like the creation of a new “Health Data Research Service (HDRS) in partnership with the Wellcome Trust and backed by up to £600 million of joint investment”. Sounds good. Similarly, a focus on genomics at scale could truly enable the shift from reactive to preventative care. I like the sound of it, but reading between the lines, it seems their ambition is that the UK private sector, rather than the NHS, leads the way in genomics and data at scale.

Also at the Curia event were presentations from Seamus Harrison from Genomics and Angela McFarlane from IQVIA. Genomics is a transatlantic TechBio business using large-scale genomic data to predict disease risk and improve drug discovery. IQVIA is a global company that uses large-scale health data, advanced analytics, and AI to support clinical research and bring new medical treatments to market. Both companies are innovating the big picture stuff that the NHS should be falling over itself to adopt. The event, and events like it, though, are still in the hand-wringing phase; around why the NHS can’t adopt innovation fast enough.

What I find personally worrying (after all, I rely on the NHS for my healthcare), is that the 10 year ‘plan’ is such a mixed bucket list of lofty ambition and fixing the mess. I think that for clarity, there should be two work streams. One should be about mopping up the mess and playing catch-up, and another should be focused on how to harness AI to transform preventative care. If they could do that well, then maybe they wouldn’t need to spend £25 billion on more appointments.

The danger in lumping it all together is that politicians will naturally focus on quick wins “booking GP appointments online” is the very first thing this plan mentions, after all, rather than tackling the harder stuff.

By having such a broad and confused remit, the danger is that the NHS falls further behind. After all the clues are there. Brilliant health tech companies are, of course, global. They can go anywhere. Let’s not lose them and lose out to health systems elsewhere that can move more quickly.

Katie Lips is CEO and Founder of Rebel Futures. She helps organisations grasp the opportunities at technology inflection points, from the early web and pre-iPhone mobile to cloud-based SaaS and now AI. She has held senior roles at EY and Aimia, and was Head of Digital Policy at Which?. Katie holds a Harvard Kennedy School qualification in Leading in Artificial Intelligence and is a Founder Institute graduate.

Related: explore our work on AI Transformation.

base44
Edit with Base44